Perception of Health, Mistrust, Anxiety, and Indecision in a Group of Italians Vaccinated against COVID-19
Abstract
:1. Introduction
2. Methods
2.1. Participants
2.2. Instruments
2.3. Procedure
3. Statistical Analysis
4. Results
5. Discussion
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Borriello, A.; Master, D.; Pellegrini, A.; Rose, J.M. Preferences for a COVID-19 vaccine in Australia. Vaccine 2021, 39, 473–479. [Google Scholar] [CrossRef]
- Karafillakis, E.; Dinca, I.; Apfel, F.; Cecconi, S.; Wűrz, A.; Takacs, J.; Suk, J.; Celentano, L.P.; Kramarz, P.; Larson, H.J. Vaccine hesitancy among healthcare workers in Europe: A qualitative study. Vaccine 2016, 34, 5013–5020. [Google Scholar] [CrossRef] [PubMed]
- Reiter, P.L.; Pennell, M.L.; Katz, M.L. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine 2020, 38, 6500–6507. [Google Scholar] [CrossRef]
- Manning, M.L.; Gerolamo, A.M.; Marino, M.A.; Hanson-Zalot, M.E.; Pogorzelska-Maziarz, M. COVID-19 vaccination readiness among nurse faculty and student nurses. Nurs. Outlook 2021. [Google Scholar] [CrossRef]
- Detoc, M.; Bruel, S.; Frappe, P.; Tardy, B.; Botelho-Nevers, E.; Gagneux-Brunon, A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine 2020, 38, 7002–7006. [Google Scholar] [CrossRef] [PubMed]
- Kwok, K.O.; Li, K.K.; Wei, W.I.; Tang, A.; Wong, S.Y.S.; Lee, S.S. Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey. Int. J. Nurs. Stud. 2021, 114, 103854. [Google Scholar] [CrossRef] [PubMed]
- Palgi, Y.; Bergman, Y.S.; Ben-David, B.; Bodner, E. No psychological vaccination: Vaccine hesitancy is associated with negative psychiatric outcomes among Israelis who received COVID-19 vaccination. J. Affect. Disord. 2021, 287, 352–353. [Google Scholar] [CrossRef]
- Byrne, T.E.; Patel, P.; Shrotri, M.; Beale, S.; Michie, S.; Butt, J.; Hawkins, N.; Hardelid, P.; Rodger, A.; Aryee, A.; et al. Trends, patterns and psychological influences on COVID-19 vaccination intention: Findings from a large prospective community cohort study in England and Wales (Virus Watch). medRxiv 2021. [Google Scholar] [CrossRef]
- Murphy, J.; Vallières, F.; Bentall, R.P.; Shevlin, M.; McBride, O.; Hartman, T.K.; McKay, R.; Bennett, K.; Mason, L.; Gibson-Miller, J.; et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat. Commun. 2021, 12, 29. [Google Scholar] [CrossRef] [PubMed]
- Trujillo, K.L.; Motta, M. A Majority of Vaccine Skeptics Plan to Refuse a COVID-19 Vaccine, a Study Suggests, and that could be a Big Problem. Conversation, 4 May 2020.
- Graffigna, G.; Palamenghi, L.; Boccia, S.; Barello, S. Relationship between citizens’ health engagement and intention to take the COVID-19 vaccine in Italy: A mediation analysis. Vaccines 2020, 8, 576. [Google Scholar] [CrossRef] [PubMed]
- Ward, J.K.; Alleaume, C.; Peretti-Watel, P.; Seror, V.; Cortaredona, S.; Launay, O.; Raude, J.; Verger, P.; Beck, F.; Legleye, S.; et al. The French public’s attitudes to a future COVID-19 vaccine: The politicization of a public health issue. Soc. Sci. Med. 2020, 265, 113414. [Google Scholar] [CrossRef]
- Salali, G.D.; Uysal, M.S. COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey. Psychol. Med. 2020, 1–3. [Google Scholar] [CrossRef] [PubMed]
- Shrotri, M.; Swinnen, T.; Kampmann, B.; Parker, E.P. An interactive website tracking COVID-19 vaccine development. Lancet Glob. Health 2021, 9, e590–e592. [Google Scholar] [CrossRef]
- Shim, E. Optimal Allocation of the Limited COVID-19 Vaccine Supply in South Korea. J. Clin. Med. 2021, 10, 591. [Google Scholar] [CrossRef]
- Madison, A.A.; Shrout, M.R.; Renna, M.E.; Kiecolt-Glaser, J.K. Psychological and Behavioral Predictors of Vaccine Efficacy: Considerations for COVID-19. Perspect. Psychol. Sci. 2021, 16, 191–203. [Google Scholar] [CrossRef] [PubMed]
- Available online: http://vaccinicovid19.regione.campania.it/vaccini-anti-covid.html (accessed on 31 May 2021).
- Available online: https://statistichecoronavirus.it/coronavirus-italia/coronavirus-campania/ (accessed on 31 May 2021).
- Available online: https://www.governo.it/it/cscovid19/report-vaccini/ (accessed on 31 May 2021).
- Available online: https://www.aifa.gov.it/farmacovigilanza-vaccini-covid-19 (accessed on 31 May 2021).
- Spielberger, C.D.; Gorsuch, R.; Lushene, R. Manual for the State-Trait Anxiety Inventory; Consulting Psychologist Press: Palo Alto, CA, USA, 1970. [Google Scholar]
- Ware, J.E.; Kosinski, M.; Keller, S.D. A 12-Item Short-Form Health Survey. Med. Care 1996, 34, 220–233. [Google Scholar] [CrossRef] [Green Version]
- DeRoo, S.S.; Pudalov, N.J.; Fu, L.Y. Planning for a COVID-19 Vaccination Program. JAMA 2020, 323, 2458–2459. [Google Scholar] [CrossRef] [PubMed]
- Fisher, A.; Mbaeyi, S.; Cohn, A. Commentary: Addressing vaccine hesitancy in the age of COVID-19. Acad. Pediatr. 2021, 21, s3–s4. [Google Scholar] [CrossRef] [PubMed]
- Davin, B.; Jardin, M.; Guerrera, H.; Mabille, J.; Tréhard, H.; Lapalus, D.; Guagliardo, V. L’impact de l’épidémie de COVID-19 sur les soins de premier recours en région Provence-Alpes-Côte d’Azur: Retour d’expérience sur la mise en place d’un dispositif de surveillance en temps réel à partir des données régionales de l’Assurance maladie. Revue d’Épidémiologie et de Santé Publique 2021, 69, 105–115. [Google Scholar] [CrossRef] [PubMed]
- Lang, R.; Benham, J.L.; Atabati, O.; Hollis, A.; Tombe, T.; Shaffer, B.; Oxoby, R.J. Attitudes, behaviours and barriers to public health measures for COVID-19: A survey to inform public health messaging. BMC Public Health 2021, 21, 1–15. [Google Scholar] [CrossRef] [PubMed]
- Depoux, A.; Martin, S.; Karafillakis, E.; Preet, R.; Wilder-Smith, A.; Larson, H. The pandemic of social media panic travels faster than the COVID-19 outbreak. J. Travel Med. 2020, 27. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chou, W.-Y.S.; Budenz, A. Considering Emotion in COVID-19 Vaccine Communication: Addressing Vaccine Hesitancy and Fostering Vaccine Confidence. Health Commun. 2020, 35, 1718–1722. [Google Scholar] [CrossRef]
- Beaudoin-Bussières, G.; Laumaea, A.; Anand, S.P.; Prévost, J.; Gasser, R.; Goyette, G.; Finzi, A. Decline of humoral responses against SARS-CoV-2 spike in convalescent individuals. mBio 2020. [Google Scholar] [CrossRef]
- Bener, A.; Morgul, E.; Atak, M.; Barışık, C.C. The Impact of COVID-19 Pandemic Disease Exposed with Mental Health in Turkey. Int. J. Clin. Psychiatry Ment. Health 2020, 8, 16–19. [Google Scholar] [CrossRef]
- Cohen, S. Psychosocial vulnerabilities to upper respiratory infectious illness: Implications for susceptibility to coronavirus disease 2019 (COVID-19). Perspect. Psychol. Sci. 2021, 16, 161. [Google Scholar] [CrossRef] [PubMed]
- Barello, S.; Palamenghi, L.; Graffigna, G. Looking inside the ‘black box’ of vaccine hesitancy: Unlocking the effect of psychological attitudes and beliefs on COVID-19 vaccine acceptance and implications for public health communication. Psychol. Med. 2021, 1–2. [Google Scholar] [CrossRef]
- Sun, S.; Lin, D.; Operario, D. Interest in COVID-19 vaccine trials participation among young adults in China: Willingness, reasons for hesitancy, and demographic and psychosocial determinants. Prev. Med. Rep. 2021, 22, 101350. [Google Scholar] [CrossRef] [PubMed]
- Barello, S.; Nania, T.; Dellafiore, F.; Graffigna, G.; Caruso, R. ‘Vaccine hesitancy’ among university students in Italy during the COVID-19 pandemic. Eur. J. Epidemiol. 2020, 35, 781–783. [Google Scholar] [CrossRef]
% | M | SD | |
---|---|---|---|
F | 54.2 | 55.88 | 71.14 |
M | 45.8 | 56.89 | 27.67 |
1 dose | 65.8 | 54.21 | 26.26 |
2 dose | 34.2 | 60.16 | 86.97 |
Cominarty (Pfizer-BioNTech) | 75.7 | 60.51 | 62.36 |
Vaxzevria (Astrazeneca) | 24.3 | 42.48 | 11.91 |
Medical and health personnel | 28.1 | 38.39 | 27.19 |
Administrative staff | 10.6 | 46.22 | 11.32 |
School staff | 15.6 | 43.41 | 11.7 |
University staff | 3.1 | 29.96 | 3.8 |
People with frailty | 10.3 | 47.45 | 14.03 |
People with disabilities | 0.4 | 52.43 | 7.8 |
Law enforcement agencies | 1.1 | 46.82 | 10.24 |
People with advanced age | 28.8 | 87.73 | 88.32 |
Subjects aged between 70–79 years | 2 | 74.93 | 4.61 |
Sex | Type of Vaccine | Vaccine Dose Comirnaty (Pfizer-BioNTech) | ||||
---|---|---|---|---|---|---|
Calm and Peaceful? | F | M | Comirnaty (Pfizer-BioNTech) | Vaxzevria (AstraZeneca) | 1st | 2nd |
All of the time | 10.9% | 18.6% | 15.9% | 9.5% | 12.3% | 18.3% |
Most of the time | 31.6% | 41.1% | 36.3% | 34.4% | 36% | 35.5% |
A good bit of the time | 17.1% | 15.9% | 15.7% | 19.3% | 17.7% | 14.5% |
Some of the time | 30.9% | 19.3% | 24.2% | 30.4% | 26.9% | 23.5% |
A little of the time | 8.6% | 3.7% | 6.4% | 6.1% | 6.1% | 6.9% |
None of the time | 0.8% | 1.4% | 1.4% | 0.3% | 1% | 1.3% |
Priority Ministerial Categories | |||||||||
---|---|---|---|---|---|---|---|---|---|
Calm and Peaceful? | Subjects with Advanced Age (over 80s) | Medical and Health Staff | Administrative Staff | Subjects Aged |70–79| Years | School Staff | University Staff | People with Frailty | People with Disabilities | Law Enforcement Agencies |
All of the time | 20% | 15% | 12.2% | 21.4% | 7.4% | 10.2% | 7.7% | 14.3% | 29.4% |
Most of the time | 29% | 42.6% | 36% | 25% | 35.7% | 30.6% | 39.1% | 28.6% | 52.9% |
A good bit of the time | 17.1% | 16.1% | 18.3% | 7.1% | 20.1% | 18.4% | 11.5% | 28.6% | 0% |
Some of the time | 23.4% | 21.4% | 26.8% | 35.7% | 31.6% | 36.7% | 30.8% | 28.6% | 5.9% |
A little of the time | 9.4% | 3.2% | 5.5% | 7.1% | 5.3% | 4.1% | 10.9% | 0% | 0% |
None of the time | 1.1% | 1.6% | 1.2% | 3.6% | 0% | 0% | 0% | 0% | 11.8% |
Sex | Type of Vaccine | Vaccine Dose Comirnaty (Pfizer-BioNTech) | ||||
---|---|---|---|---|---|---|
Downhearted and Blue? | F | M | Comirnaty (Pfizer-BioNTech) | Vaxzevria (AstraZeneca) | 1 | 2 |
All of the time | 1.9% | 1.1% | 1.3% | 2% | 1.7% | 1.1% |
Most of the time | 5.7% | 1.6% | 4.4% | 2.2% | 3.5% | 4.7% |
A good bit of the time | 10.6% | 5.9% | 8.9% | 7% | 7.8% | 9.7% |
Some of the time | 36.9% | 25.1% | 30.3% | 34.2% | 32.8% | 27.6% |
A little of the time | 32.1% | 41.9% | 34.6% | 41.2% | 37.3% | 35.1% |
None of the time | 12.9% | 24.4% | 20.6% | 13.4% | 16.8% | 21.8% |
Priority Ministerial Categories | |||||||||
---|---|---|---|---|---|---|---|---|---|
Downhearted and Blue? | Subjects with Advanced Age (over 80s) | Medical and Health Staff | Administrative Staff | Subjects Aged |70–79| Years | School Staff | University Staff | People with Frailty | People with Disabilities | Law Enforcement Agencies |
All of the time | 2.2% | 0% | 2% | 0% | 1.8% | 0% | 6.1% | 0% | 0% |
Most of the time | 7.8% | 1.2% | 0.7% | 11.8% | 2.7% | 2.2% | 6.1% | 25% | 0% |
A good bit of the time | 10.3% | 7.9% | 4% | 5.9% | 8.1% | 6.7% | 10.2% | 50% | 0% |
Some of the time | 31.2% | 29.4% | 31.3% | 17.6% | 35.9% | 44.4% | 24.5% | 0% | 11.1% |
A little of the time | 27.3% | 41.5% | 44% | 41.2% | 39% | 35.6% | 38.8% | 25% | 22.2% |
None of the time | 21.2% | 20% | 18% | 23.5% | 12.6% | 11.1% | 14.3% | 0% | 66.7% |
Sex | Type of Vaccine | Vaccine Dose | ||||
---|---|---|---|---|---|---|
Item #2 I Feel Secure | F | M | Comirnaty (Pfizer-BioNTech) | Vaxzevria (AstraZeneca) | 1 | 2 |
Not at all | 5.7% | 3.4% | 4.2% | 5.9% | 4.5% | 4.8% |
Somewhat | 0% | 0% | 0% | 0% | 0% | 0% |
Moderately so | 78% | 66.9% | 72.3% | 75.5% | 72.9% | 73.1% |
Very much so | 16.2% | 29.7% | 23.5% | 18.6% | 22.6% | 22.1% |
Item #3 I feel tense | F | M | Comirnaty (Pfizer-BioNTech) | Vaxzevria (AstraZeneca) | 1 | 2 |
Not at all | 41.5% | 59.1% | 53.4% | 36.8% | 46.9% | 54.4% |
Somewhat | 42.6% | 32.1% | 34.8% | 48.4% | 40.7% | 32.7% |
Moderately so | 13.1% | 6.7% | 9.7% | 11.6% | 9.8% | 10.9% |
Very much so | 2.7% | 2.1% | 2.1% | 3.2% | 2.6% | 1.9% |
Item #9 I feel frightened | F | M | Comirnaty (Pfizer-BioNTech) | Vaxzevria (AstraZeneca) | 1 | 2 |
Not at all | 59.5% | 76.5% | 69.2% | 60.3% | 65% | 71% |
Somewhat | 30.4% | 17.6% | 23% | 30.4% | 26.4% | 21.8% |
Moderately so | 9% | 4.7% | 6.8% | 7.9% | 7.3% | 6.4% |
Very much so | 1.1% | 1.2% | 1% | 1.4% | 1.3% | 0.8% |
Item #12 I feel nervous | F | M | Comirnaty (Pfizer-BioNTech) | Vaxzevria (AstraZeneca) | 1 | 2 |
Not at all | 52.1% | 62.9% | 61.1% | 43.6% | 54.3% | 62.3% |
Somewhat | 33.6% | 29.1% | 27.5% | 43.9% | 33.8% | 26.8% |
Moderately so | 11.8% | 6.7% | 9.3% | 10.3% | 9.9% | 8.8% |
Very much so | 2.5% | 1.3% | 2% | 2.2% | 2% | 2.1% |
Item #14 I feel indecisive | F | M | Comirnaty (Pfizer-BioNTech) | Vaxzevria (AstraZeneca) | 1 | 2 |
Not at all | 60.8% | 71.4% | 67.9% | 58.6% | 66% | 65.2% |
Somewhat | 28.2% | 21.8% | 23.7% | 30.3% | 25.1% | 25% |
Moderately so | 8.6% | 5.1% | 6.1% | 9.5% | 7.4% | 6% |
Very much so | 2.4% | 1.8% | 2.3% | 1.6% | 1.4% | 3.7% |
Item #2 I Feel Secure | |||||||||
---|---|---|---|---|---|---|---|---|---|
Subjects with Advanced Age (over 80s) | Medical and Health Staff | Administrative Staff | Subjects Aged |70–79| Years | School Staff | University Staff | People with Frailty | People with Disabilities | Law Enforcement Agencies | |
Not at all | 3.6% | 3.5% | 5.1% | 0% | 6.2% | 4.1% | 9.2% | 0% | 0% |
Somewhat | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Moderately so | 65.5% | 77.5% | 80.8% | 69% | 73.6% | 83.7% | 73% | 83.3% | 58.8% |
Very much so | 30.9% | 19% | 14.1% | 31% | 20.2% | 12.2% | 17.8% | 16.7% | 41.2% |
Item #3 I Feel Tense | |||||||||
Subjects with Advanced Age (over 80s) | Medical and Health Staff | Administrative Staff | Subjects Aged |70–79| Years | School Staff | University Staff | People with Frailty | People with Disabilities | Law Enforcement Agencies | |
Not at all | 67% | 44.2% | 37.6% | 58.6% | 38% | 37.5% | 42.1% | 50% | 70.6% |
Somewhat | 25.2% | 40.5% | 48.4% | 41.4% | 47.5% | 47.9% | 40.8% | 50% | 23.5% |
Moderately so | 6.6% | 13.3% | 9.6% | 0% | 12.4% | 8.3% | 12.5% | 0% | 5.9% |
Very much so | 1.1% | 2.1% | 4.5% | 0% | 2.1% | 6.3% | 4.6% | 0% | 0% |
Item #9 I Feel Frightened | |||||||||
Subjects with Advanced Age (over 80s) | Medical and Health Staff | Administrative Staff | Subjects Aged |70–79| Years | School Staff | University Staff | People with Frailty | People with Disabilities | Law Enforcement Agencies | |
Not at all | 75.9% | 68.5% | 59.5% | 65.5% | 61.9% | 56.3% | 56.6% | 83.3% | 64.7% |
Somewhat | 17.8% | 23.1% | 32.3% | 34.5% | 29.7% | 33.3% | 30.9% | 16.7% | 17.6% |
Moderately so | 5.7% | 7.4% | 7% | 0% | 6.7% | 10.4% | 10.5% | 0% | 11.8% |
Very much so | 0.7% | 0.9% | 1.3% | 0% | 1.7% | 0% | 2% | 0% | 5.9% |
Item #12 I Feel Nervous | |||||||||
Subjects with Advanced Age (over 80s) | Medical and Health Staff | Administrative Staff | Subjects Aged |70–79| Years | School Staff | University Staff | People with Frailty | People with Disabilities | Law Enforcement Agencies | |
Not at all | 75.2% | 54.7% | 46.5% | 46.5% | 42.9% | 41.7% | 43.3% | 20% | 70.6% |
Somewhat | 16.4% | 32.8% | 38.9% | 38.9% | 45% | 45.8% | 39.3% | 80% | 23.5% |
Moderately so | 6.8% | 10.6% | 12.1% | 12.1% | 10.4% | 8.3% | 13.3% | 0% | 5.9% |
Very much so | 1.6% | 1.8% | 2.5% | 2.5% | 1.7% | 4.2% | 4% | 0% | 0% |
Item #14 I Feel Indecisive | |||||||||
Subjects with Advanced Age (over 80s) | Medical and Health Staff | Administrative Staff | Subjects Aged |70–79| Years | School Staff | University Staff | People with Frailty | People with Disabilities | Law Enforcement Agencies | |
Not at all | 76.6% | 61.9% | 61.4% | 79.3% | 58.8% | 53.1% | 59.2% | 83.3% | 76.5% |
Somewhat | 15.2% | 29.1% | 26.6% | 20.7% | 30% | 38.8% | 32.2% | 16.7% | 23.5% |
Moderately so | 6.3% | 5.6% | 9.5% | 0% | 9.6% | 8.2% | 7.2% | 0% | 0% |
Very much so | 1.8% | 3.5% | 2.5% | 0% | 1.7% | 0% | 1.3% | 0% | 0% |
PCS | MCS | |||
---|---|---|---|---|
M | SD | M | SD | |
F | 12.69 | 1.92 | 17.40 | 3.01 |
M | 12.58 | 2.03 | 17.23 | 3.44 |
Medical and health personnel | 12.72 | 1.88 | 17.35 | 3.09 |
Administrative staff | 13.32 | 1.65 | 18.34 | 2.53 |
School staff | 13.16 | 1.52 | 18.10 | 2.34 |
University staff | 13.02 | 1.46 | 17.86 | 2.6 |
People with frailty | 11.61 | 2.26 | 14.74 | 3.72 |
People with disabilities | 10.86 | 2.47 | 14.14 | 4.91 |
Law enforcement agencies | 12.12 | 1.93 | 16.0 | 3.20 |
People with advanced age | 12.48 | 1.96 | 17.60 | 3.12 |
Subjects aged between 70–79 years | 11.23 | 3.57 | 15.29 | 5.86 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Moccia, G.; Carpinelli, L.; Savarese, G.; Borrelli, A.; Boccia, G.; Motta, O.; Capunzo, M.; De Caro, F. Perception of Health, Mistrust, Anxiety, and Indecision in a Group of Italians Vaccinated against COVID-19. Vaccines 2021, 9, 612. https://doi.org/10.3390/vaccines9060612
Moccia G, Carpinelli L, Savarese G, Borrelli A, Boccia G, Motta O, Capunzo M, De Caro F. Perception of Health, Mistrust, Anxiety, and Indecision in a Group of Italians Vaccinated against COVID-19. Vaccines. 2021; 9(6):612. https://doi.org/10.3390/vaccines9060612
Chicago/Turabian StyleMoccia, Giuseppina, Luna Carpinelli, Giulia Savarese, Anna Borrelli, Giovanni Boccia, Oriana Motta, Mario Capunzo, and Francesco De Caro. 2021. "Perception of Health, Mistrust, Anxiety, and Indecision in a Group of Italians Vaccinated against COVID-19" Vaccines 9, no. 6: 612. https://doi.org/10.3390/vaccines9060612
APA StyleMoccia, G., Carpinelli, L., Savarese, G., Borrelli, A., Boccia, G., Motta, O., Capunzo, M., & De Caro, F. (2021). Perception of Health, Mistrust, Anxiety, and Indecision in a Group of Italians Vaccinated against COVID-19. Vaccines, 9(6), 612. https://doi.org/10.3390/vaccines9060612